Global and China Covid-19 Diagnostic Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunoassay
1.2.3 Genomic and WGS Role
1.2.4 rRT-PCR
1.3 Market by Application
1.3.1 Global Covid-19 Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Laboratory
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Diagnostic Market Perspective (2016-2027)
2.2 Covid-19 Diagnostic Growth Trends by Regions
2.2.1 Covid-19 Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Covid-19 Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Covid-19 Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Covid-19 Diagnostic Industry Dynamic
2.3.1 Covid-19 Diagnostic Market Trends
2.3.2 Covid-19 Diagnostic Market Drivers
2.3.3 Covid-19 Diagnostic Market Challenges
2.3.4 Covid-19 Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Diagnostic Players by Revenue
3.1.1 Global Top Covid-19 Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Covid-19 Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Covid-19 Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Diagnostic Revenue
3.4 Global Covid-19 Diagnostic Market Concentration Ratio
3.4.1 Global Covid-19 Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Diagnostic Revenue in 2020
3.5 Covid-19 Diagnostic Key Players Head office and Area Served
3.6 Key Players Covid-19 Diagnostic Product Solution and Service
3.7 Date of Enter into Covid-19 Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Diagnostic Breakdown Data by Type
4.1 Global Covid-19 Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Covid-19 Diagnostic Forecasted Market Size by Type (2022-2027)
5 Covid-19 Diagnostic Breakdown Data by Application
5.1 Global Covid-19 Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Covid-19 Diagnostic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Covid-19 Diagnostic Market Size (2016-2027)
6.2 North America Covid-19 Diagnostic Market Size by Type
6.2.1 North America Covid-19 Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Covid-19 Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Covid-19 Diagnostic Market Size by Type (2016-2027)
6.3 North America Covid-19 Diagnostic Market Size by Application
6.3.1 North America Covid-19 Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Covid-19 Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Covid-19 Diagnostic Market Size by Application (2016-2027)
6.4 North America Covid-19 Diagnostic Market Size by Country
6.4.1 North America Covid-19 Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Covid-19 Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Covid-19 Diagnostic Market Size (2016-2027)
7.2 Europe Covid-19 Diagnostic Market Size by Type
7.2.1 Europe Covid-19 Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Covid-19 Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Covid-19 Diagnostic Market Size by Type (2016-2027)
7.3 Europe Covid-19 Diagnostic Market Size by Application
7.3.1 Europe Covid-19 Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Covid-19 Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Covid-19 Diagnostic Market Size by Application (2016-2027)
7.4 Europe Covid-19 Diagnostic Market Size by Country
7.4.1 Europe Covid-19 Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Covid-19 Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Covid-19 Diagnostic Market Size by Type
8.2.1 Asia-Pacific Covid-19 Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Covid-19 Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Covid-19 Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Covid-19 Diagnostic Market Size by Application
8.3.1 Asia-Pacific Covid-19 Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Covid-19 Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Covid-19 Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Covid-19 Diagnostic Market Size by Region
8.4.1 Asia-Pacific Covid-19 Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Covid-19 Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Covid-19 Diagnostic Market Size (2016-2027)
9.2 Latin America Covid-19 Diagnostic Market Size by Type
9.2.1 Latin America Covid-19 Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Covid-19 Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Covid-19 Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Covid-19 Diagnostic Market Size by Application
9.3.1 Latin America Covid-19 Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Covid-19 Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Covid-19 Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Covid-19 Diagnostic Market Size by Country
9.4.1 Latin America Covid-19 Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Covid-19 Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Covid-19 Diagnostic Market Size by Type
10.2.1 Middle East & Africa Covid-19 Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Covid-19 Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Covid-19 Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Covid-19 Diagnostic Market Size by Application
10.3.1 Middle East & Africa Covid-19 Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Covid-19 Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Covid-19 Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Covid-19 Diagnostic Market Size by Country
10.4.1 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Covid-19 Diagnostic Introduction
11.1.4 Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.1.5 Abbott Diagnostics Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Covid-19 Diagnostic Introduction
11.2.4 Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.2.5 Accelerate Diagnostics Recent Development
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Details
11.3.2 Ador Diagnostics Business Overview
11.3.3 Ador Diagnostics Covid-19 Diagnostic Introduction
11.3.4 Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.3.5 Ador Diagnostics Recent Development
11.4 Akkoni Biosystems
11.4.1 Akkoni Biosystems Company Details
11.4.2 Akkoni Biosystems Business Overview
11.4.3 Akkoni Biosystems Covid-19 Diagnostic Introduction
11.4.4 Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2016-2021)
11.4.5 Akkoni Biosystems Recent Development
11.5 Alveo Technologies
11.5.1 Alveo Technologies Company Details
11.5.2 Alveo Technologies Business Overview
11.5.3 Alveo Technologies Covid-19 Diagnostic Introduction
11.5.4 Alveo Technologies Revenue in Covid-19 Diagnostic Business (2016-2021)
11.5.5 Alveo Technologies Recent Development
11.6 Applied BioCode
11.6.1 Applied BioCode Company Details
11.6.2 Applied BioCode Business Overview
11.6.3 Applied BioCode Covid-19 Diagnostic Introduction
11.6.4 Applied BioCode Revenue in Covid-19 Diagnostic Business (2016-2021)
11.6.5 Applied BioCode Recent Development
11.7 Aus Diagnostics
11.7.1 Aus Diagnostics Company Details
11.7.2 Aus Diagnostics Business Overview
11.7.3 Aus Diagnostics Covid-19 Diagnostic Introduction
11.7.4 Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.7.5 Aus Diagnostics Recent Development
11.8 BD Diagnostics
11.8.1 BD Diagnostics Company Details
11.8.2 BD Diagnostics Business Overview
11.8.3 BD Diagnostics Covid-19 Diagnostic Introduction
11.8.4 BD Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.8.5 BD Diagnostics Recent Development
11.9 Biocartis
11.9.1 Biocartis Company Details
11.9.2 Biocartis Business Overview
11.9.3 Biocartis Covid-19 Diagnostic Introduction
11.9.4 Biocartis Revenue in Covid-19 Diagnostic Business (2016-2021)
11.9.5 Biocartis Recent Development
11.10 BioFire Diagnostics
11.10.1 BioFire Diagnostics Company Details
11.10.2 BioFire Diagnostics Business Overview
11.10.3 BioFire Diagnostics Covid-19 Diagnostic Introduction
11.10.4 BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.10.5 BioFire Diagnostics Recent Development
11.11 bioMérieux
11.11.1 bioMérieux Company Details
11.11.2 bioMérieux Business Overview
11.11.3 bioMérieux Covid-19 Diagnostic Introduction
11.11.4 bioMérieux Revenue in Covid-19 Diagnostic Business (2016-2021)
11.11.5 bioMérieux Recent Development
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Details
11.12.2 Bio-Rad Laboratories Business Overview
11.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Introduction
11.12.4 Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2016-2021)
11.12.5 Bio-Rad Laboratories Recent Development
11.13 Bosch Healthcare Solutions GmbH
11.13.1 Bosch Healthcare Solutions GmbH Company Details
11.13.2 Bosch Healthcare Solutions GmbH Business Overview
11.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Introduction
11.13.4 Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2016-2021)
11.13.5 Bosch Healthcare Solutions GmbH Recent Development
11.14 Cepheid
11.14.1 Cepheid Company Details
11.14.2 Cepheid Business Overview
11.14.3 Cepheid Covid-19 Diagnostic Introduction
11.14.4 Cepheid Revenue in Covid-19 Diagnostic Business (2016-2021)
11.14.5 Cepheid Recent Development
11.15 Co-Diagnostics
11.15.1 Co-Diagnostics Company Details
11.15.2 Co-Diagnostics Business Overview
11.15.3 Co-Diagnostics Covid-19 Diagnostic Introduction
11.15.4 Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.15.5 Co-Diagnostics Recent Development
11.16 Cue Health
11.16.1 Cue Health Company Details
11.16.2 Cue Health Business Overview
11.16.3 Cue Health Covid-19 Diagnostic Introduction
11.16.4 Cue Health Revenue in Covid-19 Diagnostic Business (2016-2021)
11.16.5 Cue Health Recent Development
11.17 Curetis
11.17.1 Curetis Company Details
11.17.2 Curetis Business Overview
11.17.3 Curetis Covid-19 Diagnostic Introduction
11.17.4 Curetis Revenue in Covid-19 Diagnostic Business (2016-2021)
11.17.5 Curetis Recent Development
11.18 Diagenode Diagnostics
11.18.1 Diagenode Diagnostics Company Details
11.18.2 Diagenode Diagnostics Business Overview
11.18.3 Diagenode Diagnostics Covid-19 Diagnostic Introduction
11.18.4 Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.18.5 Diagenode Diagnostics Recent Development
11.18 Diascopic
11.25.1 Diascopic Company Details
11.25.2 Diascopic Business Overview
11.25.3 Diascopic Covid-19 Diagnostic Introduction
11.25.4 Diascopic Revenue in Covid-19 Diagnostic Business (2016-2021)
11.25.5 Diascopic Recent Development
11.20 Diasorin
11.20.1 Diasorin Company Details
11.20.2 Diasorin Business Overview
11.20.3 Diasorin Covid-19 Diagnostic Introduction
11.20.4 Diasorin Revenue in Covid-19 Diagnostic Business (2016-2021)
11.20.5 Diasorin Recent Development
11.21 Expedeon
11.21.1 Expedeon Company Details
11.21.2 Expedeon Business Overview
11.21.3 Expedeon Covid-19 Diagnostic Introduction
11.21.4 Expedeon Revenue in Covid-19 Diagnostic Business (2016-2021)
11.21.5 Expedeon Recent Development
11.22 Fusion Genomics.
11.22.1 Fusion Genomics. Company Details
11.22.2 Fusion Genomics. Business Overview
11.22.3 Fusion Genomics. Covid-19 Diagnostic Introduction
11.22.4 Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2016-2021)
11.22.5 Fusion Genomics. Recent Development
11.23 GenePOC Diagnostics
11.23.1 GenePOC Diagnostics Company Details
11.23.2 GenePOC Diagnostics Business Overview
11.23.3 GenePOC Diagnostics Covid-19 Diagnostic Introduction
11.23.4 GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.23.5 GenePOC Diagnostics Recent Development
11.24 GenMark Dx
11.24.1 GenMark Dx Company Details
11.24.2 GenMark Dx Business Overview
11.24.3 GenMark Dx Covid-19 Diagnostic Introduction
11.24.4 GenMark Dx Revenue in Covid-19 Diagnostic Business (2016-2021)
11.24.5 GenMark Dx Recent Development
11.25 Hologic
11.25.1 Hologic Company Details
11.25.2 Hologic Business Overview
11.25.3 Hologic Covid-19 Diagnostic Introduction
11.25.4 Hologic Revenue in Covid-19 Diagnostic Business (2016-2021)
11.25.5 Hologic Recent Development
11.26 Immunexpress
11.26.1 Immunexpress Company Details
11.26.2 Immunexpress Business Overview
11.26.3 Immunexpress Covid-19 Diagnostic Introduction
11.26.4 Immunexpress Revenue in Covid-19 Diagnostic Business (2016-2021)
11.26.5 Immunexpress Recent Development
11.27 Inflammatix
11.27.1 Inflammatix Company Details
11.27.2 Inflammatix Business Overview
11.27.3 Inflammatix Covid-19 Diagnostic Introduction
11.27.4 Inflammatix Revenue in Covid-19 Diagnostic Business (2016-2021)
11.27.5 Inflammatix Recent Development
11.28 Invetech
11.28.1 Invetech Company Details
11.28.2 Invetech Business Overview
11.28.3 Invetech Covid-19 Diagnostic Introduction
11.28.4 Invetech Revenue in Covid-19 Diagnostic Business (2016-2021)
11.28.5 Invetech Recent Development
11.29 Janssen Diagnostics
11.29.1 Janssen Diagnostics Company Details
11.29.2 Janssen Diagnostics Business Overview
11.29.3 Janssen Diagnostics Covid-19 Diagnostic Introduction
11.29.4 Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.29.5 Janssen Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Covid-19 Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoassay
Table 3. Key Players of Genomic and WGS Role
Table 4. Key Players of rRT-PCR
Table 5. Global Covid-19 Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Covid-19 Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Covid-19 Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Covid-19 Diagnostic Market Share by Regions (2016-2021)
Table 9. Global Covid-19 Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Covid-19 Diagnostic Market Share by Regions (2022-2027)
Table 11. Covid-19 Diagnostic Market Trends
Table 12. Covid-19 Diagnostic Market Drivers
Table 13. Covid-19 Diagnostic Market Challenges
Table 14. Covid-19 Diagnostic Market Restraints
Table 15. Global Covid-19 Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Covid-19 Diagnostic Market Share by Players (2016-2021)
Table 17. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Diagnostic as of 2020)
Table 18. Ranking of Global Top Covid-19 Diagnostic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Covid-19 Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Covid-19 Diagnostic Product Solution and Service
Table 22. Date of Enter into Covid-19 Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Covid-19 Diagnostic Revenue Market Share by Type (2016-2021)
Table 26. Global Covid-19 Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Covid-19 Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Covid-19 Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Covid-19 Diagnostic Revenue Market Share by Application (2016-2021)
Table 30. Global Covid-19 Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Covid-19 Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Covid-19 Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Covid-19 Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Covid-19 Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Covid-19 Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Covid-19 Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Covid-19 Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Diagnostics Company Details
Table 63. Abbott Diagnostics Business Overview
Table 64. Abbott Diagnostics Covid-19 Diagnostic Product
Table 65. Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 66. Abbott Diagnostics Recent Development
Table 67. Accelerate Diagnostics Company Details
Table 68. Accelerate Diagnostics Business Overview
Table 69. Accelerate Diagnostics Covid-19 Diagnostic Product
Table 70. Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 71. Accelerate Diagnostics Recent Development
Table 72. Ador Diagnostics Company Details
Table 73. Ador Diagnostics Business Overview
Table 74. Ador Diagnostics Covid-19 Diagnostic Product
Table 75. Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 76. Ador Diagnostics Recent Development
Table 77. Akkoni Biosystems Company Details
Table 78. Akkoni Biosystems Business Overview
Table 79. Akkoni Biosystems Covid-19 Diagnostic Product
Table 80. Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 81. Akkoni Biosystems Recent Development
Table 82. Alveo Technologies Company Details
Table 83. Alveo Technologies Business Overview
Table 84. Alveo Technologies Covid-19 Diagnostic Product
Table 85. Alveo Technologies Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 86. Alveo Technologies Recent Development
Table 87. Applied BioCode Company Details
Table 88. Applied BioCode Business Overview
Table 89. Applied BioCode Covid-19 Diagnostic Product
Table 90. Applied BioCode Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 91. Applied BioCode Recent Development
Table 92. Aus Diagnostics Company Details
Table 93. Aus Diagnostics Business Overview
Table 94. Aus Diagnostics Covid-19 Diagnostic Product
Table 95. Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 96. Aus Diagnostics Recent Development
Table 97. BD Diagnostics Company Details
Table 98. BD Diagnostics Business Overview
Table 99. BD Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 100. BD Diagnostics Recent Development
Table 101. Biocartis Company Details
Table 102. Biocartis Business Overview
Table 103. Biocartis Covid-19 Diagnostic Product
Table 104. Biocartis Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 105. Biocartis Recent Development
Table 106. BioFire Diagnostics Company Details
Table 107. BioFire Diagnostics Business Overview
Table 108. BioFire Diagnostics Covid-19 Diagnostic Product
Table 109. BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 110. BioFire Diagnostics Recent Development
Table 111. bioMérieux Company Details
Table 112. bioMérieux Business Overview
Table 113. bioMérieux Covid-19 Diagnostic Product
Table 114. bioMérieux Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 115. bioMérieux Recent Development
Table 116. Bio-Rad Laboratories Company Details
Table 117. Bio-Rad Laboratories Business Overview
Table 118. Bio-Rad Laboratories Covid-19 Diagnostic Product
Table 119. Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 120. Bio-Rad Laboratories Recent Development
Table 121. Bosch Healthcare Solutions GmbH Company Details
Table 122. Bosch Healthcare Solutions GmbH Business Overview
Table 123. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product
Table 124. Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 125. Bosch Healthcare Solutions GmbH Recent Development
Table 126. Cepheid Company Details
Table 127. Cepheid Business Overview
Table 128. Cepheid Covid-19 Diagnostic Product
Table 129. Cepheid Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 130. Cepheid Recent Development
Table 131. Co-Diagnostics Company Details
Table 132. Co-Diagnostics Business Overview
Table 133. Co-Diagnostics Covid-19 Diagnostic Product
Table 134. Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 135. Co-Diagnostics Recent Development
Table 136. Cue Health Company Details
Table 137. Cue Health Business Overview
Table 138. Cue Health Covid-19 Diagnostic Product
Table 139. Cue Health Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 140. Cue Health Recent Development
Table 141. Curetis Company Details
Table 142. Curetis Business Overview
Table 143. Curetis Covid-19 Diagnostic Product
Table 144. Curetis Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 145. Curetis Recent Development
Table 146. Diagenode Diagnostics Company Details
Table 147. Diagenode Diagnostics Business Overview
Table 148. Diagenode Diagnostics Covid-19 Diagnostic Product
Table 149. Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 150. Diagenode Diagnostics Recent Development
Table 151. Diascopic Company Details
Table 152. Diascopic Business Overview
Table 153. Diascopic Covid-19 Diagnostic Product
Table 154. Diascopic Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 155. Diascopic Recent Development
Table 156. Diasorin Company Details
Table 157. Diasorin Business Overview
Table 158. Diasorin Covid-19 Diagnostic Product
Table 159. Diasorin Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 160. Diasorin Recent Development
Table 161. Expedeon Company Details
Table 162. Expedeon Business Overview
Table 163. Expedeon Covid-19 Diagnostic Product
Table 164. Expedeon Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 165. Expedeon Recent Development
Table 166. Fusion Genomics. Company Details
Table 167. Fusion Genomics. Business Overview
Table 168. Fusion Genomics. Covid-19 Diagnostic Product
Table 169. Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 170. Fusion Genomics. Recent Development
Table 171. GenePOC Diagnostics Company Details
Table 172. GenePOC Diagnostics Business Overview
Table 173. GenePOC Diagnostics Covid-19 Diagnostic Product
Table 174. GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 175. GenePOC Diagnostics Recent Development
Table 176. GenMark Dx Company Details
Table 177. GenMark Dx Business Overview
Table 178. GenMark Dx Covid-19 DiagnosticProduct
Table 179. GenMark Dx Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 180. GenMark Dx Recent Development
Table 181. Hologic Company Details
Table 182. Hologic Business Overview
Table 183. Hologic Covid-19 Diagnostic Product
Table 184. Hologic Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 185. Hologic Recent Development
Table 186. Immunexpress Company Details
Table 187. Immunexpress Business Overview
Table 188. Immunexpress Covid-19 Diagnostic Product
Table 189. Immunexpress Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 190. Immunexpress Recent Development
Table 191. Inflammatix Company Details
Table 192. Inflammatix Business Overview
Table 193. Inflammatix Covid-19 Diagnostic Product
Table 194. Inflammatix Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 195. Inflammatix Recent Development
Table 196. Invetech Company Details
Table 197. Invetech Business Overview
Table 198. Invetech Covid-19 Diagnostic Product
Table 199. Invetech Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 200. Invetech Recent Development
Table 201. Janssen Diagnostics Company Details
Table 202. Janssen Diagnostics Business Overview
Table 203. Janssen Diagnostics Covid-19 Diagnostic Product
Table 204. Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 205. Janssen Diagnostics Recent Development
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Covid-19 Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Immunoassay Features
Figure 3. Genomic and WGS Role Features
Figure 4. rRT-PCR Features
Figure 5. Global Covid-19 Diagnostic Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Laboratory Case Studies
Figure 8. Covid-19 Diagnostic Report Years Considered
Figure 9. Global Covid-19 Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Covid-19 Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Covid-19 Diagnostic Market Share by Regions: 2020 VS 2027
Figure 12. Global Covid-19 Diagnostic Market Share by Regions (2022-2027)
Figure 13. Global Covid-19 Diagnostic Market Share by Players in 2020
Figure 14. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Diagn